Navid Sobhani
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 24
- Cancer-related Molecular Pathways 7
- Cancer Immunotherapy and Biomarkers 7
-
- Advanced Breast Cancer Therapies 7
- Prostate Cancer Treatment and Research 5
- Co-authors
- Giandomenico Roviello (22 shared papers)Alberto D’Angelo (25 shared papers)Yong Li (8 shared papers)Daniele Generali (11 shared papers)Daniele Generali (22 shared papers)Raheleh Roudi (11 shared papers)Silvia Paola Corona (12 shared papers)Aram Davtyan (2 shared papers)
- Journals
- Cancers (11 papers)International Journal of Molecular Sciences (4 papers)Cells (3 papers)Investigational New Drugs (2 papers)Future Oncology (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Navid Sobhani
57 papers receiving 1.4k citations
Navid Sobhani's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 519
- Cancer Research 209
- Immunology 277
- Pulmonary and Respiratory Medicine 365
- Molecular Biology 536
Countries citing papers authored by Navid Sobhani
This map shows the geographic impact of Navid Sobhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Sobhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Sobhani more than expected).
Fields of papers citing papers by Navid Sobhani
This network shows the impact of papers produced by Navid Sobhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Sobhani. The network helps show where Navid Sobhani may publish in the future.
Co-authors
The 25 scholars most cited alongside Navid Sobhani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 201 | |
| 2 | 2019 | 125 | |
| 3 | 2011 | 86 | |
| 4 | The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects Hit paper breakdown → | 2024 | 81 |
| 5 | 2018 | 79 | |
| 6 | 2020 | 71 | |
| 7 | 2022 | 61 | |
| 8 | 2020 | 51 | |
| 9 | 2021 | 47 | |
| 10 | 2021 | 42 | |
| 11 | 2021 | 41 | |
| 12 | 2018 | 37 | |
| 13 | 2017 | 32 | |
| 14 | 2021 | 30 | |
| 15 | 2018 | 29 | |
| 16 | 2019 | 28 | |
| 17 | 2022 | 24 | |
| 18 | 2018 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2018 | 21 |
About Navid Sobhani
Navid Sobhani is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Cancer Research, having authored 58 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Prostate Cancer Treatment and Research (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (519 citations), Cancer Research (209 citations), Immunology (277 citations), Pulmonary and Respiratory Medicine (365 citations) and Molecular Biology (536 citations). Navid Sobhani has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Giandomenico Roviello, Alberto D’Angelo, Yong Li, Daniele Generali, Daniele Generali, Raheleh Roudi, Silvia Paola Corona, Aram Davtyan, Fabrizio Zanconati and Praveen Neeli. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Cells, Investigational New Drugs and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.